Nimbus site 143 — New York, New York

Nimbus site 143 is a clinical research site located in New York, New York, United States 10075.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Nimbus site 143 has participated in 1 clinical trials.

Therapeutic areas: Moderate to Severe Plaque Psoriasis.

Sponsors: Takeda.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nimbus site 143?

Nimbus site 143 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nimbus site 143 conducted?

Nimbus site 143 has 1 clinical trials on record. Their work covers Moderate to Severe Plaque Psoriasis.

Is Nimbus site 143 accredited by Crixeo Health?

Nimbus site 143 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nimbus site 143?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.